How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

A lot is being said about the way that the new LCD(s) around Cellular Tissue Products (CTPs) / skin substitutes might impact access to care. A big issue is around product choice and ensuring that there is a large enough suite of covered products from which physicians...